Clinical Trials of a New Drug, Ibufenac, in the Treatment of Rheumatoid Arthritis: A PRELIMINARY REPORT
Open Access
- 1 September 1963
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 22 (5), 358-362
- https://doi.org/10.1136/ard.22.5.358
Abstract
The results of 3 clinical trials of a new antiinflammatory/analgesic substance (4-isobutylphenylacetic acid: Ibufenac) in patients with rheumatoid arthritis are presented and discussed. It is concluded that Ibufenac is a useful drug in the treatment of the symptoms of rheumatoid arthritis. It appears to be as effective as aspirin in this respect at the dosage levels employed and its use was associated with considerably fewer side effects.Keywords
This publication has 3 references indexed in Scilit:
- Effect of Aspirin on Cutaneous Response to the Local Application of an Ester of Nicotinic AcidAnnals Of The Rheumatic Diseases, 1959
- DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.1959
- Diagnostic Criteria for Rheumatoid Arthritis: 1958 RevisionAnnals Of The Rheumatic Diseases, 1959